Research & Innovation
During VCU Massey's recent installment of the Director’s Distinguished Visiting Scholars Seminar Series (DDVSSS), Gregory Abel, M.D., MPH, spoke on the importance of exercising caution around the integration of artificial intelligence into cancer research and patient care. ...
Clinical Care, Prevention , Patient Stories
A prostate cancer survivor shares why cancer screenings and access to specialized care matters for Virginia’s rural communities....
Clinical Care, Patient Stories
This September is Childhood Cancer Awareness Month, learn more about how 15-year-old Riley Oldaker's teen spirit and love of laughter has never wavered from the diagnosis of cancer to aggressive treatment and knee-replacement surgery. ...
Research & Innovation
VCU Massey researchers were recently awarded a $2.5 million R01 grant from the National Cancer Institute. The five-year grant will allow Massey to evaluate the efficacy of TROP2 targeted antibody-drug conjugates (ADCs) to further enhance therapeutic benefits in both breast and pancreatic cancer care...
Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.
Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.
Massey is proud to partner with OncLive to provide interviews and videos from thought leaders and cutting edge articles and resources on cancer.
